Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune tolerant phase
- PMID: 33119160
- DOI: 10.1111/apt.15973
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune tolerant phase
Comment in
-
Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' reply.Aliment Pharmacol Ther. 2020 Sep;52(6):1094-1095. doi: 10.1111/apt.16000. Aliment Pharmacol Ther. 2020. PMID: 33119164 No abstract available.
Comment on
-
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.Aliment Pharmacol Ther. 2020 Jul;52(1):196-204. doi: 10.1111/apt.15741. Epub 2020 May 26. Aliment Pharmacol Ther. 2020. PMID: 32452564
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical